A Study to Determine the Safety and Efficacy of the RSV F Vaccine to Protect Infants Via Maternal Immunization
Public ClinicalTrials.gov record NCT02624947. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Randomized, Observer-Blind, Placebo-Controlled, Group-Sequential Study to Determine the Immunogenicity and Safety of a Respiratory Syncytial Virus (RSV) F Nanoparticle Vaccine With Aluminum in Healthy Third-trimester Pregnant Women; and Safety and Efficacy of Maternally Transferred Antibodies in Preventing RSV Disease in Their Infants
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to determine the efficacy of maternal immunization during the third trimester of pregnancy with the RSV F vaccine against medically-significant RSV lower respiratory tract infection (LRTI), as defined by hypoxemia or tachypnea at rest, through the first 90, 120, 150, and 180 days of life in infants.
Study identification
- NCT ID
- NCT02624947
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 4,636 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 40 Years
- Sex
- Female
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 2015 (Type not available)
- Primary completion
- Dec 28, 2018 (Actual)
- Completion
- Jul 12, 2019 (Actual)
- Last update posted
- May 6, 2025
2015 – 2019
United States locations
- U.S. sites
- 49
- U.S. states
- 24
- U.S. cities
- 46
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site US115 | Birmingham | Alabama | 35233 | — |
| Research Site US035 | Cullman | Alabama | 35058 | — |
| Research Site US130 | Fort Defiance | Arizona | 86504 | — |
| Research Site US123 | Phoenix | Arizona | 85004 | — |
| Research Site US103 | Tucson | Arizona | 85712 | — |
| Research Site US129 | Whiteriver | Arizona | 85941 | — |
| Research Site US092 | Colton | California | 92324 | — |
| Research Site US114 | Huntington Park | California | 90255 | — |
| Research Site US127 | Los Angeles | California | 90057 | — |
| Research Site US091 | Madera | California | 93637 | — |
| Research Site US093 | Riverside | California | 94201 | — |
| Research Site US134 | Aurora | Colorado | 80045 | — |
| Research Site US036 | Denver | Colorado | 80204 | — |
| Research Site US040 | Washington D.C. | District of Columbia | 20010 | — |
| Research Site US037 | Blackfoot | Idaho | 83221 | — |
| Research Site US119 | Idaho Falls | Idaho | 83404 | — |
| Research Site US032 | Nampa | Idaho | 83687 | — |
| Research Site US095 | Chicago | Illinois | 60611 | — |
| Research Site US090 | West Des Moines | Iowa | 50266 | — |
| Research Site US038 | Augusta | Kansas | 67010 | — |
| Research Site US031 | Hutchinson | Kansas | 67502 | — |
| Research Site US096 | Louisville | Kentucky | 40202 | — |
| Research Site US126 | Alexandria | Louisiana | 71301 | — |
| Research Site US039 | Metairie | Louisiana | 70006 | — |
| Research Site US101 | Detroit | Michigan | 48235 | — |
| Research Site US098 | Biloxi | Mississippi | 39531 | — |
| Research Site US102 | Lincoln | Nebraska | 68516 | — |
| Research Site US025 | Norfolk | Nebraska | 68701 | — |
| Research Site US088 | Neptune City | New Jersey | 07753 | — |
| Research Site US131 | Gallup | New Mexico | 87301 | — |
| Research Site US087 | Johnson City | New York | 13790 | — |
| Research Site US086 | Syracuse | New York | 13210 | — |
| Research Site US020 | Durham | North Carolina | 27710 | — |
| Research Site US097 | Fort Bragg | North Carolina | 28310 | — |
| Research Site US089 | Englewood | Ohio | 45322 | — |
| Research Site US021 | Pittsburgh | Pennsylvania | 15213 | — |
| Research Site US116 | Beaumont | Texas | 77702 | — |
| Research Site US083 | Fort Worth | Texas | 77555 | — |
| Research Site US043 | Galveston | Texas | 77555 | — |
| Research Site US019 | Houston | Texas | 77030 | — |
| Research Site US128 | Houston | Texas | 77036 | — |
| Research Site US125 | Lampasas | Texas | 76550 | — |
| Research Site US094 | Longview | Texas | 75605 | — |
| Research Site US042 | San Antonio | Texas | 78229 | — |
| Research Site US121 | Salt Lake City | Utah | 84107 | — |
| Research Site US008 | Salt Lake City | Utah | 84124 | — |
| Research Site US099 | Salt Lake City | Utah | 84132 | — |
| Research Site US100 | Richmond | Virginia | 23220 | — |
| Research Site US041 | Seattle | Washington | 98105 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 39 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02624947, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 6, 2025 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02624947 live on ClinicalTrials.gov.